
Herceptin (Trastuzumab): Side Effects, How it Works, and More
Oct 22, 2025 · Herceptin (trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. Learn more.
HER2-Targeted Therapies for Early Breast Cancer - Susan G.
Mar 3, 2025 · Breast cancer treatment For people with HER2-positive early breast cancer, chemotherapy plus trastuzumab cuts the risk of recurrence (a return of breast cancer) in half …
Herceptin® (trastuzumab) Treatment Schedule for HER2+ Early Breast …
Read about the treatment schedule for Herceptin® (trastuzumab), a treatment for HER2+ early breast cancer. See Full Safety and Boxed Warnings for more information.
What to Know About Herceptin for HER2 - WebMD
Apr 15, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and …
Trastuzumab (Herceptin) - Breast Cancer Now
Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive …
Oct 29, 2025 · The efficacy and safety of trastuzumab deruxtecan in patients with no previous therapy for HER2-positive advanced or metastatic breast cancer are unclear.
Trastuzumab - NCI - National Cancer Institute
FDA label information for this drug is available at DailyMed. Use in Cancer Trastuzumab is approved to be used alone or with other drugs to treat: Breast cancer that is HER2 positive …
Optimized Sequencing Advances Care for HR+/HER2+ Breast Cancer
4 days ago · Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.
Herceptin for HER2-Positive Breast Cancer - HealthCentral
Nov 7, 2024 · Herceptin, a HER2 inhibitor targeted therapy, treats breast cancer. Learn if it's right for you and more here.
Targeted treatments helping patients beat breast cancer
5 days ago · Treatment options depend entirely on what type of breast cancer a patient has. Broadly, there are three main types: hormone receptor-positive (ER or PR), HER2-positive, …